Effective treatment for posttraumatic stress disorder (PTSD) centers on trauma-focused psychotherapies, with medications and supportive approaches used as adjuncts when needed. Treatments aim to reduce intrusive memories, hyperarousal, avoidance, and functional impairment that can follow exposure to violence, disasters, combat, or interpersonal trauma. Choice of therapy depends on symptom severity, comorbidities, patient preference, and local availability.
Trauma-focused psychotherapies
Proven first-line options include Prolonged Exposure, Cognitive Processing Therapy, and trauma-focused cognitive behavioral therapy. Prolonged Exposure was developed by Edna Foa at the University of Pennsylvania and teaches repeated, controlled engagement with trauma memories and avoided situations to reduce conditioned fear. Cognitive Processing Therapy grew from the work of Patricia Resick at Duke University and focuses on changing unhelpful beliefs about the trauma and its meaning. The World Health Organization recommends trauma-focused psychological therapies as core interventions in routine care for PTSD. Francine Shapiro at the EMDR Institute developed Eye Movement Desensitization and Reprocessing (EMDR), which combines trauma memory processing with bilateral stimulation and is endorsed by multiple guideline bodies as an alternative trauma-focused option.
These therapies share a focus on processing traumatic memories rather than solely managing symptoms; strong clinical practice guidelines from the Department of Veterans Affairs and Department of Defense recommend them as first-line treatments for many patients. Some people experience distress during memory processing, so delivery by trained clinicians and careful pacing are important.
Other treatments and access considerations
Pharmacotherapy can reduce core symptoms and is often used when psychotherapy is inaccessible or when comorbid depression or severe anxiety is present. The U.S. Food and Drug Administration has approved sertraline and paroxetine for PTSD, and clinical guidelines commonly recommend selective serotonin reuptake inhibitors as medication options. For patients with partial response, combining medication with trauma-focused therapy or using adjunctive approaches such as sleep-focused treatments can help address functional impairment.
Group-based therapies, family interventions, and culturally adapted programs meaningfully extend reach in communities with limited specialist providers. Cultural context matters: beliefs about trauma, stigma, and collective versus individual healing shape how interventions are received. Refugee populations, survivors of sexual violence, and military veterans may face distinct barriers—language, legal status, ongoing threat, or trust issues with institutions—that require adaptation of standard protocols.
Untreated PTSD increases risks for chronic mental health conditions, substance use, physical health problems, and social marginalization. Access to evidence-based care reduces those long-term harms and improves quality of life. Implementation requires workforce training, system-level support, and attention to equity so that evidence-based treatments reach diverse populations rather than concentrating care in specialty centers.